MARKET

TECH

TECH

Bio-Techne Corp
NASDAQ
72.47
+0.10
+0.14%
After Hours: 72.47 0 0.00% 17:31 09/21 EDT
OPEN
72.50
PREV CLOSE
72.37
HIGH
72.54
LOW
72.44
VOLUME
3.73M
TURNOVER
--
52 WEEK HIGH
72.58
52 WEEK LOW
43.07
MARKET CAP
11.36B
P/E (TTM)
62.57
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TECH last week (0914-0918)?
Weekly Report · 18h ago
Is Bio-Techne (TECH) Reasonable On Cash Flow Or Too Rich?
Simply Wall St · 5d ago
Bio-Techne Supplements Merger Proxy Amid Shareholder Litigation
TipRanks · 09/14 21:35
Weekly Report: what happened at TECH last week (0907-0911)?
Weekly Report · 09/14 09:38
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
NASDAQ · 09/11 15:30
Weekly Report: what happened at TECH last week (0831-0904)?
Weekly Report · 09/07 09:35
Bio-Techne (TECH), What Is Behind The Latest Attention?
Simply Wall St · 09/02 12:23
Bio-Techne Announces SBTi Validation Of 70% Scope 1 & 2 Emissions Reduction Target By FY2031 And Supplier Engagement Commitment, Reporting Significant Operational Emissions Cuts In FY2026
Benzinga · 09/01 10:36
More
About TECH
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.

Webull offers BIO-TECHNE Corp stock information, including NASDAQ: TECH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TECH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TECH stock methods without spending real money on the virtual paper trading platform.